Alluzience (Single vial)

Alluzience is an anti-wrinkle injection and prescription-only medicine. It’s specifically designed for aesthetic use. Alluzience has an active ingredient called botulinum toxin type A, which is used for the temporary improvement in the appearance of moderate to severe glabellar lines (vertical lines between the eyebrows). It’s a temporary measure to improve the overall appearance of the skin by smoothing out unwanted wrinkles in clients.

Alluzience is already diluted.

This is a prescription only medicine and should only be administered by trained medical professionals with the requisite experience in the application of Botulinum toxin type A.l

Please note: this is a prescription only item, and requires a prescription from a UK prescriber before dispatch

Box contents:

Each box contains x1 Alluzience 125UI Vials

Composition: 

Each vial contains 125 Speywood units of Clostridium botulinum type A toxin-haemagglutinin complex in 0.625 ml of solution. Clear colourless solution.

Key Features:

Relaxes the muscles to prevent contractions

Blocks transport of the neurotransmitter acetylcholine across the neuromuscular junction, located between the nerve end and the muscle fibre

Used in the treatment of moderate to severe wrinkles in patients

Treatment Areas:

Forehead 

Crows feet 

Frown lines

Masseter muscle 

Bunny lines 

Glabellar lines 

Chin

Lip flip 

Armpit

Contraindications of Alluzience:

Hypersensitivity to the active substance or to any of the excipients

Presence of infection at the proposed injection sites

Presence of myasthenia gravis, Eaton Lambert Syndrome or amyotrophic lateral sclerosis

Who Should Not Use Alluzience: 

Pregnant and lactating women should not use this product as not enough clinical data has been collected to suggest that it is safe. There is a risk of this product passing through the mother to her baby

Any individuals who develop hypersensitivity or an allergic reaction to the product should also refrain from using it. Children under 18 and adults over 65 should also not use this product

Anyone with an infection on the skin surface at the proposed injection site should wait for the infection to completely disappear first

If there is a probable muscle weakness (myasthenia gravis) already present, then do not use Alluzience either. The following diseases and conditions should also rule out the use of this medicine: Eaton Lambert syndrome and amyotrophic lateral sclerosis (degenerative nerve muscle disorder)

Duration:

Alluzience can last up to 6 months

Storage Temp:

Store in refrigerator 2-8°C

For use by trained professionals only